Final Results of a Non-Interventional Study Evaluating the Quality of Life in Second-line Treatment of Metastatic Renal Cell Carcinoma With Everolimus: The EVERPRO Study

16. April 2019

Goebell, P.J., Hermann, E., Kube, U., Doehn, C., Marschner, N., Dietel, A., Blumenstengel, K., Grimm, M.-O., Scheffler, M., Rogler, A., Bergmann, L.

Oncol Res Treat 42(1–2). doi:10.1159/000494278